Correction to:[89Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer (European Journal of Nuclear Medicine and Molecular Imaging, (2020), 47, 4, (849-859), 10.1007/s00259-019-04555-6)

Autor: van Helden, E. J., Elias, S. G., Gerritse, S. L., van Es, S. C., Boon, E., Huisman, M. C., van Grieken, N. C.T., Dekker, H., van Dongen, G. A.M.S., Vugts, D. J., Boellaard, R., van Herpen, C. M.L., de Vries, E. G.E., Oyen, W. J.G., Brouwers, A. H., Verheul, H. M.W., Hoekstra, O. S., der Houven van Oordt, C. W.Menke van

Publikováno v: van Helden, E J, Elias, S G, Gerritse, S L, van Es, S C, Boon, E, Huisman, M C, van Grieken, N C T, Dekker, H, van Dongen, G A M S, Vugts, D J, Boellaard, R, van Herpen, C M L, de Vries, E G E, Oyen, W J G, Brouwers, A H, Verheul, H M W, Hoekstra, O S & der Houven van Oordt, C W M V 2020, ' Correction to : [89Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer (European Journal of Nuclear Medicine and Molecular Imaging, (2020), 47, 4, (849-859), 10.1007/s00259-019-04555-6) ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 47, no. 10, pp. 2481 . https://doi.org/10.1007/s00259-020-04908-6

The Electronic Supplementary Materials are missing in the original article. Kindly check the Electronic Supplementary Materials in this article. The Publisher regrets this error.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_____10172::0c0938e5110305b00cc0d60e8bed533c
https://research.vumc.nl/en/publications/0c4bd5ae-9627-44b4-9087-a375c3e76a80

Anti-CEA Antibody Fragments Labeled with [18F]AlF for PET Imagingof CEA-Expressing Tumors.

Autor: Lütje, S., Franssen, G. M., Sharkey, R. M., Laverman, P., Rossi, E. A., Goldenberg, D. M., Oyen, W. J.G., Boerman, O. C., McBride, W. J.

Publikováno v: Bioconjugate Chemistry; Feb2014, Vol. 25 Issue 2, p335-341, 7p

¹³¹I-cG250 monoclonal antibody immunoscintigraphy versus [¹⁸F]FDG-PET imaging in patients with metastatic renal cell carcinoma: a comparative study.

Autor: BROUWERS, A. H., DÖRR, U., LANG, O., BOERMAN, O. C., OYEN, W. J.G., STEFFENS, M. G., OOSTERWIJK, E., MERGENTHALER, H. G., BIHL, H., CORSTENS, F. H.M.

Publikováno v: Nuclear Medicine Communications; Mar2002, Vol. 23 Issue 3, p229-236, 8p

Dynamic distribution and dosimetric evaluation of human non-specific immunoglobulin G labelled with ¹¹¹In or ⁹⁹Tc^m.

Autor: BUIJS, W. C.A.M., OYEN, W. J.G., DAMS, E. Th.M., BOERMAN, O. C., SIEGEL, J. A., CLAESSENS, R. A.M.J., VAN DER MEER, J. W.M., CORSTENS, F. H.M.

Publikováno v: Nuclear Medicine Communications; Aug1998, Vol. 19 Issue 8, p743-752, 10p

Biodistribution of ¹¹¹In-labelled IgG and IgM in experimental infection.

Autor: OYEN, W. J.G., BOERMAN, O. C., SUBRAMANIAN, R., KOENDERS, E. B., CLAESSENS, R. A.M.J., VAN DER MEER, J. W.M., CORSTENS, F. H.M.

Publikováno v: Nuclear Medicine Communications; Jul1996, Vol. 17 Issue 7, p616-620, 5p